182 related articles for article (PubMed ID: 14603530)
1. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
Liou JS; Chen JS; Faller DV
J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
3. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2.
Chen CY; Faller DV
Oncogene; 1995 Oct; 11(8):1487-98. PubMed ID: 7478573
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
5. p21ras function is important for T cell antigen receptor and protein kinase C regulation of nuclear factor of activated T cells.
Woodrow MA; Rayter S; Downward J; Cantrell DA
J Immunol; 1993 May; 150(9):3853-61. PubMed ID: 8473736
[TBL] [Abstract][Full Text] [Related]
6. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G
Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
[TBL] [Abstract][Full Text] [Related]
7. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis.
Davis MA; Chang SH; Trump BF
Toxicol Appl Pharmacol; 1996 Nov; 141(1):93-101. PubMed ID: 8917680
[TBL] [Abstract][Full Text] [Related]
9. Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo.
Jasinski P; Zwolak P; Terai K; Dudek AZ
Transl Res; 2008 Nov; 152(5):203-12. PubMed ID: 19010291
[TBL] [Abstract][Full Text] [Related]
10. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
Long IS; Han K; Li M; Shirasawa S; Sasazuki T; Johnston M; Tsao MS
Mol Cancer Res; 2003 Mar; 1(5):393-401. PubMed ID: 12651912
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C is not a downstream effector of p21ras in activated T cells.
Williams DH; Woodrow M; Cantrell DA; Murray EJ
Eur J Immunol; 1995 Jan; 25(1):42-7. PubMed ID: 7843251
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
14. The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas.
D'Costa AM; Robinson JK; Maududi T; Chaturvedi V; Nickoloff BJ; Denning MF
Oncogene; 2006 Jan; 25(3):378-86. PubMed ID: 16158048
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
Cheng G; Meinkoth JL
Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes.
Bernhard EJ; McKenna WG; Hamilton AD; Sebti SM; Qian Y; Wu JM; Muschel RJ
Cancer Res; 1998 Apr; 58(8):1754-61. PubMed ID: 9563495
[TBL] [Abstract][Full Text] [Related]
17. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis.
Meyer E; Vollmer JY; Bovey R; Stamenkovic I
Cancer Res; 2005 May; 65(10):4261-72. PubMed ID: 15899818
[TBL] [Abstract][Full Text] [Related]
19. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
